SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-017052
Filing Date
2020-07-09
Accepted
2020-07-09 11:54:08
Documents
41
Period of Report
2020-05-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0520_bespokeextracts.htm 10-Q 580082
2 CERTIFICATION f10q0520ex31-1_bespoke.htm EX-31.1 11520
3 CERTIFICATION f10q0520ex32-1_bespoke.htm EX-32.1 4501
  Complete submission text file 0001213900-20-017052.txt   2763838

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bspk-20200531.xml EX-101.INS 369367
5 XBRL SCHEMA FILE bspk-20200531.xsd EX-101.SCH 34581
6 XBRL CALCULATION FILE bspk-20200531_cal.xml EX-101.CAL 33261
7 XBRL DEFINITION FILE bspk-20200531_def.xml EX-101.DEF 149877
8 XBRL LABEL FILE bspk-20200531_lab.xml EX-101.LAB 237409
9 XBRL PRESENTATION FILE bspk-20200531_pre.xml EX-101.PRE 197495
Mailing Address 323 SUNNY ISLES BOULEVARD SUITE 700 SUNNY ISLES FL 33160
Business Address 323 SUNNY ISLES BOULEVARD SUITE 700 SUNNY ISLES FL 33160 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

IRS No.: 204743354 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52759 | Film No.: 201019994
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences